Form 8-K - Current report:
SEC Accession No. 0001641172-25-002908
Filing Date
2025-04-07
Accepted
2025-04-07 06:20:21
Documents
13
Period of Report
2025-03-31
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35221
  Complete submission text file 0001641172-25-002908.txt   205328

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE rgbp-20250331.xsd EX-101.SCH 3042
3 XBRL LABEL FILE rgbp-20250331_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE rgbp-20250331_pre.xml EX-101.PRE 22377
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3460
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

EIN.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 25816308
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)